GlassScriptPhysician profile
Taral Shah
NPI 1831357946
$383.98
in general payments reported to CMS, 2019-2025
7 companies · $91.95 in 2025
The $91.95 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.33 · 2020: $39.28 · 2021: $46.34 · 2022: $58.24 · 2023: $40.72 · 2024: $28.12 · 2025: $91.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $91.95 · Food and Beverage: $68.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $91.95 |
| Food and Beverage | $68.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $151.33 | 2019-2025 | |
| Amgen INC. | $103.38 | 2021-2023 | Lumakras |
| E.R. Squibb & Sons, L.L.C. | $40.44 | 2020-2021 | |
| Tesaro, INC. | $30.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $21.93 | 2023 | Tagrisso |
| Genzyme Corporation | $18.83 | 2020 | |
| Merck Sharp & Dohme LLC | $18.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taral Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.